Login

Enzymatica presents positive in-vitro results | August 2023 - Claus Egstrand,CEO, Enzymatica AB (publ) 00:00:00

Share On Facebook Share On Twitter

Enzymatica presents positive in-vitro results | August 2023

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Uro Medals CEO Cole Evans Discusses Newmont Lake Property and 2024 Exploration Plans
00:10:00
An interview with Donald McGarva CEO of Aferian plc | Donald McGarva, Group CEO, Amino Technologies PLCAMO:LSE
00:10:00
Russophobia and Anti-Semitism in Russian Nationalism: A Complex Nexus|Gary Saul Morson,Professor,Northwestern University
00:10:00
ESG Trends in Mining: A Financial Perspective by Société Générale
00:10:00
Insights from ENEA SA Management Board President at Congress 590 |Paweł Majewski, CEO, ENEA SA.
00:10:00
Embracing Growth in Your 50s: A Time for Personal and Financial Expansion | Ron Bernstein, Co-Founder, Prism Planning Partners, LLC.
00:10:00
Strong Quarter for Yes Bank: Profit Surges 38% as Provisions Decline | Mike Dunbar, CEO , Mamba Exploration.
00:10:00
MolyWorks Improves Air-Worthy Aerospace Part Production Capabilities | Jeffrey A Graves, CEO, 3D Systems CorpDDD*:MEX
00:10:00
What makes a Great Founder|Magnus Grimeland,Founder and CEO,Antler
00:10:00
Perspectives on Sustainable Investment and Global Economic Trends | Josh Green, CEO,The Mather Group.
00:10:00
Strategies for Identifying Investment Opportunities Amid Market Volatility | Ali Dibadj , CEO , Janus Henderson.
00:10:00
TAURON Polska Energia SA's Strong First Quarter Performance | Marek Wadowski, Vice-President ,Tauron Polska Energia SA.

© 2017 - Neuhu+